Diarrhoea and ARI with its associated symptoms such as fever, cough and difficulty in breathing are among the most common forms of childhood morbidity, which lead to about one-fifth of child deaths globally.
Diarrhoea and acute respiratory infection (ARI) with their associated symptoms such as fever, cough and difficulty in breathing are among the most common forms of childhood morbidity which lead to millions of deaths worldwide each year.
This may partly be explained by the hypothesis that patients developing nosocomial infections have more co-morbidities which lead to longer inpatient care per se and therefore exposes them to the risk of hospital-acquired infections for a longer time period.
Autologous graft therapies using tissues from colon, and small and large intestine or gastric transplantations have been attempted but have constraints like leakage, infection and stenosis at the implanted site, which leads to severe morbidity and mortality.
The root-knot nematode (Meloidogyne incognita) attacks and forms galls on the roots, which leads to the morbidity or death of the plant.
However, increased antimicrobial resistance is exacerbating impact on public health worldwide, which leads to increased morbidity, mortality, and treatment costs [ 8, 9].
Co-infection rate of hepatitis B virus and HIV is common which leads to increased morbidity and mortality as compared to HIV or HBV mono-infections [ 11, 12].
As a consequence, antipsychotics drugs are frequently prescribed before alternative nonpharmacological approaches are attempted, and patients are maintained in medication for long periods, which leads to increasing morbidity and mortality.
While specific treatments have been developed for ERα+ BC (tamoxifen, aromatase inhibitors) and HER2+ BC (trastuzumab), the only option for most TNBC patients is cytotoxic chemotherapy such as anthracyclines (doxorubicin), which leads to significant morbidity.
